SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?


To: The Ox who wrote (2280)2/1/2018 11:07:45 PM
From: Miljenko Zuanic  Respond to of 3559
 
Well, you may have something day early from SNY conference,... but than again...what they can say? "We have a great collaboration with REGN"?



To: The Ox who wrote (2280)2/2/2018 2:47:46 AM
From: Miljenko Zuanic  Read Replies (1) | Respond to of 3559
 
...assumptions??? You want a bet?

medpagetoday.com

DME is where Eylea can penetrate further and deeper.
That is why Roche Ang-2/VEGF combo may hurt Eylea significantly, after 2021 when it should be (IF???) approved.